OGN vs TGEN · P/E 3.4, rev $3.02B vs rev $12.1M
Organon & Co (OGN) versus Tecogen Inc. (TGEN) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Tecogen Inc. (TGEN) is a electrical equipment & parts company listed on AMEX.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported TGEN revenue for 2026-06-30 was $12.1M. Net income was -$4.3M. Revenue was up 90.7% from 2026-03-31 to 2026-06-30. TGEN currently screens at market cap $172.9M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. TGEN currently screens at market cap $172.9M.
Not investment advice. Open the OGN and TGEN stock pages for the full models.
Not investment advice.